drugset / Trial / NCT02349360
Safety, Tolerability and Host Response to Lactobacillus Johnsonii
Phase 1/2
Completed
42 enrolled
University of Florida
Juvenile Diabetes Research Foundation · collab
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this research study is to determine the effects of the probiotic, Lactobacillus johnsonii N6.2, on safety, gastrointestinal function, wellness, fecal bacteria and blood biomarkers in healthy individuals.
Timeline
- Start
- 2015-08
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lactobacillus | Unknown | 1e+10 unknown | Oral |
Indications
No indication recorded.